| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pulmonary Embolism | 13 | 2020 | 4775 | 2.37 | Why? |
| Hemodynamics | 8 | 2020 | 1562 | 1.68 | Why? |
| Thrombolytic Therapy | 5 | 2020 | 2218 | 1.37 | Why? |
| West Nile Fever | 2 | 2020 | 166 | 1.37 | Why? |
| Venous Thromboembolism | 6 | 2021 | 4273 | 1.25 | Why? |
| Tachycardia, Ventricular | 2 | 2019 | 251 | 1.19 | Why? |
| Percutaneous Coronary Intervention | 6 | 2021 | 3646 | 1.01 | Why? |
| ST Elevation Myocardial Infarction | 6 | 2021 | 3051 | 1.00 | Why? |
| Adjuvants, Anesthesia | 2 | 2018 | 13 | 0.96 | Why? |
| Coronary Vessels | 2 | 2018 | 914 | 0.80 | Why? |
| Air Bags | 1 | 2018 | 4 | 0.77 | Why? |
| Vena Cava Filters | 1 | 2019 | 89 | 0.71 | Why? |
| Heart Failure, Diastolic | 1 | 2017 | 21 | 0.70 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 1510 | 0.70 | Why? |
| Drugs, Investigational | 1 | 2021 | 198 | 0.70 | Why? |
| Risk Assessment | 19 | 2020 | 25439 | 0.70 | Why? |
| Myxoma | 1 | 2017 | 16 | 0.70 | Why? |
| Thoracic Injuries | 1 | 2018 | 63 | 0.69 | Why? |
| Endomyocardial Fibrosis | 1 | 2017 | 27 | 0.69 | Why? |
| Leptospirosis | 1 | 2018 | 103 | 0.69 | Why? |
| Fibrinolytic Agents | 2 | 2020 | 1702 | 0.67 | Why? |
| Midazolam | 1 | 2017 | 79 | 0.67 | Why? |
| Aorta, Abdominal | 1 | 2017 | 50 | 0.66 | Why? |
| Long Term Adverse Effects | 1 | 2018 | 119 | 0.66 | Why? |
| Nitrates | 1 | 2017 | 98 | 0.66 | Why? |
| Fentanyl | 1 | 2018 | 142 | 0.66 | Why? |
| Coronary Vessel Anomalies | 1 | 2018 | 87 | 0.64 | Why? |
| Coronary Occlusion | 1 | 2018 | 138 | 0.63 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.62 | Why? |
| Heart Neoplasms | 1 | 2017 | 77 | 0.62 | Why? |
| Auscultation | 1 | 2017 | 115 | 0.61 | Why? |
| Wounds, Nonpenetrating | 1 | 2018 | 157 | 0.61 | Why? |
| Ketamine | 1 | 2017 | 112 | 0.61 | Why? |
| Non-ST Elevated Myocardial Infarction | 2 | 2020 | 490 | 0.59 | Why? |
| Myocardial Infarction | 3 | 2021 | 3361 | 0.59 | Why? |
| Syncope | 1 | 2018 | 238 | 0.57 | Why? |
| Heart Ventricles | 4 | 2018 | 1139 | 0.57 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.56 | Why? |
| Dyslipidemias | 1 | 2021 | 791 | 0.56 | Why? |
| Coronary Artery Disease | 3 | 2018 | 2570 | 0.56 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.56 | Why? |
| Ventricular Dysfunction, Right | 2 | 2021 | 639 | 0.55 | Why? |
| Cardiovascular Diseases | 9 | 2021 | 11497 | 0.55 | Why? |
| Absorbable Implants | 1 | 2017 | 191 | 0.55 | Why? |
| Coronary Angiography | 4 | 2018 | 2275 | 0.55 | Why? |
| Bone Density | 1 | 2017 | 335 | 0.54 | Why? |
| Thrombosis | 3 | 2021 | 7504 | 0.53 | Why? |
| Computed Tomography Angiography | 6 | 2020 | 2153 | 0.52 | Why? |
| Ultrasonography, Interventional | 2 | 2018 | 560 | 0.52 | Why? |
| Platelet Aggregation Inhibitors | 3 | 2018 | 1671 | 0.52 | Why? |
| Aneurysm, Dissecting | 1 | 2018 | 303 | 0.51 | Why? |
| Accidents, Traffic | 1 | 2018 | 464 | 0.51 | Why? |
| Herpes Zoster | 1 | 2018 | 331 | 0.50 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.48 | Why? |
| Arterial Occlusive Diseases | 1 | 2017 | 363 | 0.47 | Why? |
| Acute Disease | 7 | 2020 | 6029 | 0.46 | Why? |
| Osteoporosis | 1 | 2017 | 410 | 0.45 | Why? |
| Bundle-Branch Block | 3 | 2021 | 127 | 0.43 | Why? |
| Travel-Related Illness | 1 | 2018 | 1357 | 0.43 | Why? |
| Internal Medicine | 1 | 2017 | 557 | 0.43 | Why? |
| Italy | 20 | 2021 | 38444 | 0.42 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.42 | Why? |
| Pacemaker, Artificial | 3 | 2020 | 431 | 0.40 | Why? |
| Hypertension | 3 | 2020 | 8895 | 0.40 | Why? |
| Pneumothorax | 1 | 2018 | 758 | 0.39 | Why? |
| Tomography, Optical Coherence | 1 | 2017 | 1008 | 0.38 | Why? |
| Humans | 75 | 2021 | 930598 | 0.38 | Why? |
| Vascular Diseases | 1 | 2018 | 846 | 0.37 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.37 | Why? |
| Atrial Fibrillation | 2 | 2021 | 2320 | 0.37 | Why? |
| Heparin | 2 | 2020 | 2600 | 0.35 | Why? |
| Airway Management | 1 | 2017 | 1298 | 0.34 | Why? |
| Electrocardiography | 7 | 2021 | 3957 | 0.33 | Why? |
| Heart Diseases | 2 | 2020 | 3503 | 0.31 | Why? |
| Anticoagulants | 5 | 2021 | 9563 | 0.31 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.31 | Why? |
| Cardiac Resynchronization Therapy | 2 | 2018 | 191 | 0.31 | Why? |
| Thrombectomy | 1 | 2017 | 2272 | 0.30 | Why? |
| Intubation, Intratracheal | 2 | 2020 | 3962 | 0.29 | Why? |
| Coronavirus Infections | 18 | 2020 | 253789 | 0.29 | Why? |
| Treatment Outcome | 13 | 2020 | 51732 | 0.29 | Why? |
| Internet | 2 | 2020 | 6204 | 0.29 | Why? |
| Echocardiography | 5 | 2021 | 3661 | 0.29 | Why? |
| Pneumonia, Viral | 18 | 2020 | 243684 | 0.28 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.27 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.27 | Why? |
| Heart Conduction System | 2 | 2018 | 266 | 0.27 | Why? |
| Odds Ratio | 4 | 2021 | 5861 | 0.27 | Why? |
| Intensive Care Units | 5 | 2021 | 29594 | 0.25 | Why? |
| Aged | 24 | 2021 | 215776 | 0.24 | Why? |
| Stents | 2 | 2021 | 916 | 0.24 | Why? |
| Myocarditis | 1 | 2018 | 2731 | 0.24 | Why? |
| Emergencies | 1 | 2017 | 4095 | 0.24 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.23 | Why? |
| Cardiology | 6 | 2021 | 2873 | 0.22 | Why? |
| Male | 30 | 2021 | 367725 | 0.21 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.21 | Why? |
| Air Pollutants | 2 | 2020 | 3110 | 0.21 | Why? |
| Retrospective Studies | 11 | 2020 | 105322 | 0.20 | Why? |
| Heart Rate | 3 | 2021 | 1527 | 0.20 | Why? |
| Pandemics | 20 | 2021 | 389249 | 0.20 | Why? |
| Fibrin Fibrinogen Degradation Products | 3 | 2021 | 5993 | 0.20 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.19 | Why? |
| Risk Factors | 12 | 2020 | 71621 | 0.19 | Why? |
| Prognosis | 7 | 2020 | 32490 | 0.19 | Why? |
| Tachycardia, Sinus | 1 | 2018 | 43 | 0.19 | Why? |
| Leiomyoma | 1 | 2019 | 59 | 0.19 | Why? |
| West Nile virus | 1 | 2020 | 206 | 0.19 | Why? |
| Leptospira | 1 | 2018 | 48 | 0.19 | Why? |
| Electrophysiologic Techniques, Cardiac | 2 | 2020 | 396 | 0.19 | Why? |
| Transitional Care | 1 | 2020 | 135 | 0.18 | Why? |
| Predictive Value of Tests | 3 | 2019 | 9537 | 0.18 | Why? |
| Coronary Care Units | 1 | 2020 | 224 | 0.18 | Why? |
| Follow-Up Studies | 4 | 2017 | 17020 | 0.18 | Why? |
| Heart Failure, Systolic | 1 | 2018 | 39 | 0.18 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.18 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.17 | Why? |
| Female | 26 | 2020 | 380317 | 0.17 | Why? |
| Balloon Valvuloplasty | 1 | 2017 | 49 | 0.17 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.17 | Why? |
| Cardiac Pacing, Artificial | 2 | 2018 | 160 | 0.17 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.17 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.17 | Why? |
| Middle Aged | 16 | 2020 | 270681 | 0.17 | Why? |
| Time Factors | 8 | 2021 | 31397 | 0.17 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.17 | Why? |
| Vascular Patency | 1 | 2017 | 96 | 0.17 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.16 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.16 | Why? |
| Cause of Death | 3 | 2020 | 4823 | 0.16 | Why? |
| Chi-Square Distribution | 2 | 2017 | 961 | 0.16 | Why? |
| Radiography, Interventional | 1 | 2018 | 158 | 0.16 | Why? |
| Operative Time | 1 | 2018 | 450 | 0.16 | Why? |
| Radiation Exposure | 1 | 2018 | 161 | 0.16 | Why? |
| Ceftriaxone | 1 | 2018 | 365 | 0.16 | Why? |
| Ventricular Function, Right | 2 | 2021 | 388 | 0.16 | Why? |
| Proprotein Convertase 9 | 1 | 2017 | 141 | 0.16 | Why? |
| Bradycardia | 1 | 2020 | 292 | 0.16 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.16 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.16 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.15 | Why? |
| Survival Rate | 4 | 2021 | 9206 | 0.15 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.15 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.15 | Why? |
| Unnecessary Procedures | 1 | 2018 | 175 | 0.15 | Why? |
| Seasons | 2 | 2020 | 4071 | 0.15 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.15 | Why? |
| Hemofiltration | 1 | 2017 | 155 | 0.15 | Why? |
| Tomography, X-Ray Computed | 2 | 2019 | 25144 | 0.15 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.15 | Why? |
| Rivaroxaban | 1 | 2019 | 467 | 0.15 | Why? |
| Echocardiography, Transesophageal | 2 | 2017 | 447 | 0.15 | Why? |
| ROC Curve | 2 | 2017 | 6024 | 0.14 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2021 | 669 | 0.14 | Why? |
| Steroids | 1 | 2020 | 904 | 0.14 | Why? |
| Blood Pressure Determination | 1 | 2018 | 450 | 0.14 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.14 | Why? |
| DNA, Bacterial | 1 | 2018 | 835 | 0.14 | Why? |
| Factor Xa Inhibitors | 1 | 2019 | 490 | 0.14 | Why? |
| Atrioventricular Block | 1 | 2015 | 105 | 0.14 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.14 | Why? |
| Registries | 3 | 2019 | 12327 | 0.13 | Why? |
| Radiation Dosage | 1 | 2018 | 585 | 0.13 | Why? |
| Abdomen | 1 | 2017 | 424 | 0.13 | Why? |
| Catheterization, Peripheral | 1 | 2017 | 249 | 0.13 | Why? |
| Atrial Function, Left | 2 | 2015 | 82 | 0.13 | Why? |
| Rare Diseases | 1 | 2017 | 373 | 0.13 | Why? |
| Immunologic Factors | 2 | 2020 | 4206 | 0.13 | Why? |
| Syndrome | 1 | 2018 | 1310 | 0.13 | Why? |
| Analgesics | 1 | 2017 | 451 | 0.13 | Why? |
| Aged, 80 and over | 11 | 2020 | 88759 | 0.12 | Why? |
| Patient Transfer | 1 | 2020 | 898 | 0.12 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.12 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 669 | 0.12 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.11 | Why? |
| Coronary Artery Bypass | 1 | 2018 | 629 | 0.11 | Why? |
| Aftercare | 1 | 2021 | 1637 | 0.11 | Why? |
| Drug Interactions | 1 | 2018 | 1653 | 0.11 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2017 | 552 | 0.11 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.11 | Why? |
| Adult | 9 | 2020 | 244371 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Radiography | 1 | 2018 | 1576 | 0.10 | Why? |
| Drug-Eluting Stents | 1 | 2017 | 562 | 0.10 | Why? |
| Atrial Septum | 1 | 2009 | 9 | 0.10 | Why? |
| Lung | 1 | 2019 | 31049 | 0.10 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.10 | Why? |
| Embolism, Paradoxical | 1 | 2009 | 22 | 0.10 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.10 | Why? |
| Acute Coronary Syndrome | 2 | 2020 | 2107 | 0.10 | Why? |
| Aortic Valve Stenosis | 1 | 2017 | 741 | 0.10 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.10 | Why? |
| Heart Aneurysm | 1 | 2009 | 46 | 0.09 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.09 | Why? |
| Thorax | 1 | 2018 | 1873 | 0.09 | Why? |
| Heart | 1 | 2018 | 1791 | 0.09 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 839 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.09 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.08 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 9706 | 0.08 | Why? |
| Foramen Ovale, Patent | 1 | 2009 | 153 | 0.08 | Why? |
| Heart Failure | 2 | 2018 | 6638 | 0.08 | Why? |
| Patient Admission | 2 | 2020 | 5250 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.08 | Why? |
| Critical Illness | 2 | 2020 | 17281 | 0.08 | Why? |
| Ambulatory Care | 2 | 2020 | 4947 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Frailty | 1 | 2017 | 1432 | 0.07 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
| Lymphocyte Count | 1 | 2017 | 4758 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Infection Control | 4 | 2021 | 23131 | 0.07 | Why? |
| Logistic Models | 2 | 2017 | 9089 | 0.07 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.07 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.06 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
| Severity of Illness Index | 4 | 2018 | 48226 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.05 | Why? |
| India | 1 | 2018 | 11875 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Quality of Life | 1 | 2020 | 9820 | 0.05 | Why? |
| Role | 1 | 2020 | 266 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.05 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.04 | Why? |
| Pulmonary Circulation | 1 | 2020 | 207 | 0.04 | Why? |
| Markov Chains | 1 | 2020 | 502 | 0.04 | Why? |
| Ultrafiltration | 1 | 2017 | 42 | 0.04 | Why? |
| Prosthesis Implantation | 1 | 2020 | 261 | 0.04 | Why? |
| Contraindications, Procedure | 1 | 2017 | 161 | 0.04 | Why? |
| Nitrogen Dioxide | 1 | 2020 | 488 | 0.04 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Bundle of His | 1 | 2015 | 9 | 0.04 | Why? |
| Ventricular Septum | 1 | 2015 | 14 | 0.04 | Why? |
| Medical Records | 1 | 2018 | 513 | 0.04 | Why? |
| Prosthesis Design | 1 | 2018 | 594 | 0.04 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.04 | Why? |
| Diuretics | 1 | 2017 | 326 | 0.04 | Why? |
| National Health Programs | 1 | 2021 | 807 | 0.03 | Why? |
| Ventricular Remodeling | 1 | 2018 | 349 | 0.03 | Why? |
| Action Potentials | 1 | 2015 | 368 | 0.03 | Why? |
| Societies, Medical | 2 | 2020 | 6907 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Body Fluids | 1 | 2017 | 451 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2015 | 1654 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.02 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.02 | Why? |
| Geriatric Assessment | 1 | 2017 | 1372 | 0.02 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Cardiac Catheterization | 1 | 2009 | 882 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2020 | 5002 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Case-Control Studies | 1 | 2009 | 17671 | 0.01 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.01 | Why? |